Home › Funds › ACORN CAPITAL ADVISORS, LLC › BCAX

ACORN CAPITAL ADVISORS, LLC position in BCAX

BICARA THERAPEUTICS INC · Health Care

ACORN CAPITAL ADVISORS, LLC reported holding 643,381 shares of BCAX (BICARA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$19.1M, representing 5.21% of its reported portfolio and ranking #7 among its reported holdings. ACORN CAPITAL ADVISORS, LLC has disclosed BCAX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)643.38K sh
Reported value held$19.10M
Portfolio Weight5.21%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ACORN CAPITAL ADVISORS, LLC's BCAX position evolved

ACORN CAPITAL ADVISORS, LLC first disclosed a stake in BCAX in Q4 2024 at 643,381 shares (US$11.2M). The position peaked in Q2 2026 at 643,381 shares, worth US$19.1M. Across 7 filings, ACORN CAPITAL ADVISORS, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 643,381 shares valued at US$19.1M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 643.38K $11.21M New
Q1 2025 643.38K $8.38M Hold
Q2 2025 643.38K $5.98M Hold
Q3 2025 643.38K $10.16M Hold
Q4 2025 643.38K $10.83M Hold
Q1 2026 643.38K $12.80M Hold
Q2 2026 643.38K $19.10M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BCAX and 13F data

BCAX (BICARA THERAPEUTICS INC) is a Health Care company. 58 other funds we track also report a position in BCAX — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$215.4M), Siren, L.L.C. (US$166.4M), Vestal Point Capital, LP (US$155.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BCAX

All BCAX fund holders →

FAQ

How long has ACORN CAPITAL ADVISORS, LLC held BCAX?

ACORN CAPITAL ADVISORS, LLC has disclosed BCAX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is ACORN CAPITAL ADVISORS, LLC's current position in BCAX?

As of Q2 2026, ACORN CAPITAL ADVISORS, LLC holds 643.38K shares of BCAX (BICARA THERAPEUTICS INC), valued at $19.10M, representing 5.21% of its reported portfolio and ranking #7.

Has ACORN CAPITAL ADVISORS, LLC been buying or selling BCAX?

In the latest 13F filing (Q2 2026), ACORN CAPITAL ADVISORS, LLC held unchanged its position in BCAX. The position peaked in Q2 2026 at 643.38K shares.

Which other funds hold BCAX?

Other major institutional holders of BCAX include RA CAPITAL MANAGEMENT, L.P., Siren, L.L.C., Vestal Point Capital, LP, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.